Metabolic phenotypes in pancreatic cancer

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Yu, Min ^a,b   Zhou, Quanbo ^a   Zhou, Yu ^a   Fu, Zhiqiang ^a   Tan, Langping ^a   Ye, Xiao ^a   Zeng, Bing ^a   Gao, Wenchao ^a   Zhou, Jiajia ^a   Liu, Yimin ^a   Li, Zhihua ^a   Lin, Ye ^b   Lin, Qing ^a   Chen, Rufu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BECLIN 1; CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; GLUTAMATE DEHYDROGENASE; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PROTEIN BCL 2; PROTEIN BNIP3; PROTEIN P62; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; BNIP3 PROTEIN, HUMAN; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; GLUCOSE; GLUD1 PROTEIN, HUMAN; GLUTAMINE; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR ANTIGEN;

ADULT; ARTICLE; AUTOPHAGY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; RETROSPECTIVE STUDY; TUMOR INVASION; AGED; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

ADULT; AGED; ANTIGENS, NEOPLASM; APOPTOSIS REGULATORY PROTEINS; CARBONIC ANHYDRASES; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUTAMATE DEHYDROGENASE; GLUTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PANCREATIC NEOPLASMS; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS;

EID: 84923872916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115153     Document Type: Article

References (31)

1. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314. PMID: 13298683
2. Frezza C, Gottlieb E (2009) Mitochondria in cancer: not just innocent bystanders. Semin Cancer Biol 19: 4-11. doi: 10.1016/j.semcancer.2008.11.008 PMID: 19101633
3. Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G (2013) Metabolic targets for cancer therapy. Nat Rev Drug Discov 12: 829-846. doi: 10.1038/nrd4145 PMID: 24113830
4. Zu XL, Guppy M (2004) Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Commun 313: 459-465. PMID: 14697210
5. Zheng J (2012) Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). Oncol Lett 4: 1151-1157. PMID: 23226794
6. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, et al. (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8: 3984-4001. PMID: 19923890
7. Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, et al. (2011) Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 10: 2504-2520. PMID: 21778829
8. Son J, Lyssiotis CA, Ying H, Wang X, Hua S, et al. (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496: 101-105. doi: 10.1038/nature12040 PMID: 23535601
9. Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10: 88-95. doi: 10.1016/S1470-2045(08)70337-1 PMID: 19111249
10. Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56: 1134-1152. PMID: 17625148
11. Kim S, Kim do H, Jung WH, Koo JS (2013) Metabolic phenotypes in triple-negative breast cancer. Tumour Biol 34: 1699-1712. doi: 10.1007/s13277-013-0707-1 PMID: 23443971
12. Choi J, Kim DH, Jung WH, Koo JS (2013) Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype. Breast Cancer Res 15: R78. PMID: 24020991
13. Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, et al. (2013) Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A 110: 3919-3924. doi: 10.1073/pnas.1219555110 PMID: 23407165
14. Lyssiotis CA, Son J, Cantley LC, Kimmelman AC (2013) Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance. Cell Cycle 12: 1987-1988. doi: 10.4161/cc.25307 PMID: 23759579
15. Hamada S, Masamune A, Shimosegawa T (2013) Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol 4: 331. doi: 10.3389/fphys.2013.00331 PMID: 24273517
16. Blum R, Kloog Y (2014) Metabolism addiction in pancreatic cancer. Cell Death Dis 5: e1065. doi: 10. 1038/cddis.2014.38 PMID: 24556680
17. Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123: 3678-3684. doi: 10.1172/JCI69600 PMID: 23999442
18. Hamanaka RB, Chandel NS (2012) Targeting glucose metabolism for cancer therapy. J Exp Med 209: 211-215. doi: 10.1084/jem.20120162 PMID: 22330683
19. Vander Heiden MG (2013) Exploiting tumor metabolism: challenges for clinical translation. J Clin Invest 123:3648-51. doi: 10.1172/JCI72391 PMID: 23999437
20. Hidalgo M (2012) New insights into pancreatic cancer biology. Ann Oncol 23:x135-8. PMID: 22987949
21. Knaevelsrud H, Simonsen A (2010) Fighting disease by selective autophagy of aggregate-prone proteins. FEBS Lett 584:2635-45. doi: 10.1016/j.febslet.2010.04.041 PMID: 20412801
22. Clausen TH, Lamark T, Isakson P, Finley K, Larsen KB, et al. (2010) p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy 6:330-44. PMID: 20168092
23. Nicolle B, Teralee RB, Elizabeth SH, Coleen OJ, Michelle B, et al. (2011) Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death. Biochim Biophys Acta 1812: 302-311. doi: 10.1016/j.bbadis.2010.11.013 PMID: 21138765
24. Kim JY, Cho JJ, Ha J, Park JH (2002) The carboxy terminal C-tail of BNip3 is crucial in induction of mitochondrial permeability transition in isolated mitochondria. Arch Biochem Biophys 398:147-52. PMID: 11831844
25. Hart I (2011) Eating for two: how stromal fibroblasts might nurture adjacent carcinoma cells. Cell Cycle 10: 2829-2830. PMID: 21869598
26. Salem AF, Whitaker-Menezes D, Lin Z, Martinez-Outschoorn UE, Tanowitz HB, et al. (2012) Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 11: 2545-2556. doi: 10.4161/cc.20920 PMID: 22722266
27. Dang CV (2012) Links between metabolism and cancer. Genes Dev 26: 877-890. doi: 10.1101/gad. 189365.112 PMID: 22549953
28. Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, et al. (2012) Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J Proteome Res 11:554-63. doi: 10.1021/pr2009274 PMID: 22050456
29. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21:297-308. doi: 10.1016/j.ccr.2012.02.014 PMID: 22439925
30. Cai SW, Yang SZ, Gao J, Pan K, Chedn JY, et al. (2011) Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery 149:576-84. doi: 10.1016/j. surg.2010.10.009 PMID: 21167541
31. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199-1210. PMID: 17114007